Author:
Borg Sixten,Hörstedt Ann-Sofi,Carlsson Tobias,Nilbert Mef,Larsson Anna-Maria,Ohlsson Björn
Abstract
AbstractStandardized Cancer Patient Pathways (CPPs) were introduced in Swedish healthcare starting in 2015 to improve diagnostics for patients with symptoms of cancer, patient satisfaction and equity of care between healthcare providers. An inclusion target and a time target were set. Our primary aim was to visualize the patient population going through CPPs, in terms of investigation time and indications of the various outcomes including cancer diagnoses. Our secondary aims were to examine if targets were met, and to examine frequencies of undetected cancer. We collected data from 19,204 patients starting in a CPP, and 7895 patients diagnosed with cancer in 2018 in a region of Sweden. A state transition model was developed and used as analytical framework, and patients were mapped over time in the states of the model. Visualization of the patient-flow through the model illustrates speed of investigation, time to treatment, frequencies of detected and undetected cancer. Twelve CPPs out of 28 met the inclusion target, five met the time target. After suspicion of cancer rejected, 0.8% of patients were diagnosed with the primarily suspected cancer, 1.0% with another cancer. In patients not meeting the criteria for well-founded suspicion less than 3% were later diagnosed with cancer. The visualization of the patient flow into and through standardized cancer patient pathways illustrates investigation time, events occurring and outcomes. The use of standardized cancer patient pathways detects cancer efficiently.
Publisher
Springer Science and Business Media LLC
Reference21 articles.
1. Wilkens, J., Thulesius, H., Schmidt, I. & Carlsson, C. The 2015 National Cancer Program in Sweden: Introducing standardized care pathways in a decentralized system. Health Policy 120(12), 1378–1382. https://doi.org/10.1016/j.healthpol.2016.09.008 (2016).
2. Winterling, J. et al. Exploring experiences of implementing standardized cancer patient pathways within investigatory units – A qualitative study. BMC Health Serv. Res. https://doi.org/10.1186/s12913-021-06915-1 (2021).
3. The National Board of Health and Welfare and Swedish Association of Local Authorities and Regions: Kortare Väntetider i Cancervården 2018. Överenskommelse Mellan Staten och Sveriges Kommuner och Landsting [Shorter Waiting Times in Cancer Care 2018. Agreement Between the Government and Swedish Association of Local Authorities and Regions]. Stockholm 15 December 2017. (Swedish Association of Local Authorities and Regions, 2017).
4. Collaboration of Regional Cancer Centres: RCC i Samverkans SVF-Rapport 2020. Kortare Väntetider i Cancervården – Status för Inklusions- och Ledtidsmål i SVF. En Analys av SVF-Data ur SKRs Väntetidsdatabas 2018–2020. [Shorter Waiting Times in Cancer Care—Status for Inclusion Target and Lead Time Target in Standardized Cancer Patient Pathways] Online, URL = cancercentrum.se, Accessdatum Feb 2022. (Collaboration of Regional Cancer Centres, 2021).
5. Schmidt, I., Thor, J., Davidson, T., Nilsson, F. & Carlsson, C. The national program on standardized cancer care pathways in Sweden: Observations and findings half way through. Health Policy 122(9), 945–948. https://doi.org/10.1016/j.healthpol.2018.07.012 (2018).